CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
Clinical trial NCT07432334 · RECRUITING
Trial details
- NCT number
- NCT07432334
- Sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-09-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.